Clinical Trial: Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT03655964) titled 'Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke' on Aug. 30, 2018.

Brief Summary: Single-blind, randomized, active-treatment controlled clinical study evaluating the effect of omesartan and nebivolol versus no treatment on 24-hour brachial and central aortic blood pressure in hypertensive patients with acute ischemic stroke

Study Type: Interventional

Condition: Stroke, Ischemic

Intervention: * Drug: Olmesartan

At Day 4 of stroke onset, patients with clinic BP >160/100 mmHg will receive olmesartan 20 mg once daily until Day 7 of stroke onset

Other Name: No ...